Arecor to wind up operations at Tetris Pharma subsidiary
Arecor Therapeutics announced plans to cease operations within its subsidiary Tetris Pharma during 2025 on Friday, adding ...
Investing7 天
Arecor to shut down Tetris Pharma, refocus on insulin R&D
(Nasdaq: XERS) to return the commercial rights to Ogluo®, a glucagon auto-injector pen for severe hypoglycemia. The decision follows a strategic review which highlighted the financial ...